Nuvo’s Pennsaid May Need Additional Data Before Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Canadian firm says new Phase III studies will not be necessary for the “approvable” NSAID lotion.
You may also be interested in...
Nuvo Aiming For Fourth Quarter Response To Pennsaid “Approvable” Letter
Already agreed-upon studies should be concluded in time, but FDA could require more animal data for approval of the topical NSAID.
Nuvo Aiming For Fourth Quarter Response To Pennsaid “Approvable” Letter
Already agreed-upon studies should be concluded in time, but FDA could require more animal data for approval of the topical NSAID.
Nuvo's Pennsaid “Approvable” For Osteoarthritis
Company plans to meet with FDA in early 2007 to discuss the topical non-steroidal anti-inflammatory treatment.